Achilleas Attilakos

Doctorate

Assistant ProfessorPrimary
Deparment of Pediatrics, "Attikon" University Hospital, Greece

Achilleas Attilakos
A- A+

Outline

Current Position

Assistant Professor of Pediatrics

University of Athens 3rd Pediatric Clinic

“Attikon” University Hospital

Athens Greece

Undergraduate Training

MD: National and of , , (1988-1994).

Postgraduate Training

Residency in Pediatrics: 2nd Dept of Pediatrics, Athens Children’s Hospital “P.& A. Kyriakou” (1998-2002).

Board Certification (Hellenic Academy of Pediatrics) (2003).

PhD: University of Athens, Greece, School of Medicine “Blood homocysteine levels in children with epilepsy treated with long-term antiepileptic therapy” (2001-2006).

Professional Experience

General Pediatrics Fellowship, Pediatric Department, Athens Medical Center Greece, Director: Prof Th Karpathios (2003-2008).

Lecturer in Pediatrics, University of Athens 3rd Pediatric Clinic, “Attikon” University Hospital, Athens Greece (2008-2012).

Assistant Professor of Pediatrics, University of Athens 3rd Pediatric Clinic, “Attikon” University Hospital, Athens Greece (2012-to date).

Selected Publications

[1]
Katsarou E, Attilakos A, Fessatou S, Tsapra H, Tzavara V, Dracou C. Anti-β2 glycoprotein I antibodies and ischemic stroke in a 20-month-old boy. Pediatrics 2003, 112: 188-9.
[2]
Voudris K, Attilakos A, Dimou S, Mastroyianni S, Katsarou E, Skardoutsou A, Garoufi A. Serum amylase, pancreatic amylase and lipase concentrations in epileptic children treated with carbamazepine monotherapy. Clin Chim Acta. 2004, 350: 175-80.
[3]
Voudris K, Attilakos A, Katsarou E, Garoufi A, Dimou S, Skardoutsou A, Mastroyianni S. Early alteration of bone metabolism in epileptic children receiving carbamazepine monotherapy due to the induction of the hepatic drug-metabolising enzymes. J Child Neurol. 2005, 20: 513-6.
[4]
Attilakos A, Antoniadou I. Replacing mercury sphygmomanometer in paediatric clinical practice: is there a need for a consensus conference? Arch Dis Child. 2005; 90:654.
[5]
Garoufi A, Prassouli A, Attilakos A, Voudris K, Katsarou E. Homozygous MTHFR gene mutation and recurrent stroke in an infant. Pediatr Neurol. 2006, 35: 49-51.
[6]
Voudris K, Attilakos A, Katsarou E, Mastroyianni S, Dimou S, Skardoutsou A, Prassouli A, Garoufi A. Serum amylase, pancreatic amylase and lipase concentrations in epileptic children treated with sodium valproate monotherapy. Brain Dev. 2006, 28:572-575.
[7]
Voudris K, Attilakos A, Katsarou E, Drakatos A, Dimou S, Mastroyianni S, Skardoutsou A, Prassouli A, Garoufi A. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Res. 2006, 70: 211-217.
[8]
Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res. 2006, 71: 229-232.
[9]
Attilakos A, Voudris K, Garoufi A, Mastroyianni S, Dimou S, Prassouli A, Katsarou E. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study. Eur J Paediatr Neurol. 2006; 10:237-40.
[11]
Lagona E, Sharifi F, Voutsioti A, Mavri A, Markouri M, Attilakos A. Epstein-Barr virus infectious mononucleosis associated with acute acalculous cholecystitis. Infection. 2007; 35:118-9.
[12]
Attilakos A, Voudris KA, Katsarou E, Prassouli A, Mastroyianni S, Garoufi A. Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy. Clin Neuropharmacol. 2007; 30:145-9.
[13]
Attilakos A, Katsarou E, Voudris K, Garoufi A. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia 2007; 48:205-6.
[14]
Prassouli A, Katsarou E, Attilakos A, Antoniadou I. 'Learning difficulties in children with epilepsy with idiopathic generalized epilepsy and well-controlled seizures'. Dev Med Child Neurol. 2007; 49:874; author reply 874-5.
[15]
Attilakos A, Garoufi A, Voudris K, Mastroyianni S, Fotinou A, Papadimitriou DT, Gavalakis N, Prassouli A, Katsarou E. Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship? Eur J Paediatr Neurol. 2007; 11:358-61.
[16]
Attilakos A, Palaiologou P, Lagona E, Voutsioti A, Dinopoulos A. Mycoplasma pneumoniae encephalopathy: recovery after intravenous immunoglobulin. Pediatr Neurol. 2008; 38:357-9.
[17]
Markouri M, Karpathios T, Dinopoulos A, Attilakos A, Fretzayas A, Bakoula C, Kitsiou-Tzeli S. Okamoto syndrome in a girl of Caucasian origin. Dev Med Child Neurol. 2008; 50:950-2.
[18]
Attilakos A, Katsarou E, Prassouli A, Mastroyianni S, Voudris K, Fotinou A, Garoufi A. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study. Clin Neuropharmacol. 2009; 32:32-4.
[19]
Attilakos A, Prassouli A, Hadjigeorgiou G, Lagona E, Kitsiou-Tzeli S, Galla A, Stasinopoulou A, Karpathios T. Acute acalculous cholecystitis in children with Epstein-Barr virus infection: a role for Gilbert's syndrome? Int J Infect Dis. 2009; 13:e161-4.
[20]
Manolakos E, Sarri C, Vetro A, Kefalas K, Leze E, Sofocleus C, Kitsos G, Merou K, Kokotas H, Papadopoulou A, Attilakos A, Petersen MB, Kitsiou-Tzeli S. Combined 22q11.1-q11.21 deletion with 15q11.2-q13.3 duplication identified by array-CGH in a 6 years old boy. Mol Cytogenet. 2011; 4:6.
[21]
Dinopoulos A, Karapanou O, Alexopoulou E, Tzetis M, Attilakos A, Fretzayas A. VPA-induced recurrent pancreatitis in a cystic fibrosis carrier. Eur J Paediatr Neurol. 2011; 15:453-5.
[22]
Siafakas N, Attilakos A, Vourli S, Stefos E, Meletiadis J, Nikolaidou P, Zerva L. Molecular detection and identification of enteroviruses in children admitted to a university hospital in Greece. Mol Cell Probes. 2011; 25:249-54.
[23]
Papadimitriou A, Douros K, Kleanthous K, Papadimitriou DT, Attilakos A, Fretzayas A. Pubertal maturation of contemporary Greek boys: no evidence of a secular trend. J Adolesc Health. 2011; 49:434-6.
[24]
Fretzayas A, Moustaki M, Priftis KN, Attilakos A, Lapa E, Nicolaidou P. Thrombocytosis as an overt sign of cow's milk allergic proctocolitis. Allergol Immunopathol (Madr). 2011; 39:381-3.
[25]
Karpathios T, Moustaki M, Yiallouros P, Sharifi F, Attilakos A, Papadopoulou A, Fretzayas A. Severe jaundice in two children with Kawasaki disease: a possible association with Gilbert syndrome. J Korean Med Sci. 2012; 27:101-3.
[26]
Fretzayas A, Gole E, Attilakos A, Daskalaki A, Nicolaidou P, Papadopoulou A. Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II. Pediatr Int. 2013; 55:371-3.
[27]
Tzifi F, Hawkins P, Atsali E, Kotzia D, Attilakos A. Acute hepatitis in a child heterozygous for the I259V MEFV gene variant. Prague Med Rep. 2014; 115:128-33.
[28]
Garoufi A, Koemtzidou E, Katsarou E, Dinopoulos A, Kalimeraki I, Fotinou A, Drakatos A, Attilakos A. Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study. Eur J Neurol. 2014; 21:118-23.
[29]
Dinopoulos A, Attilakos A, Paschalidou M, Tsirouda M, Garoufi A, Moustaki M, Siafakas N, Papaevangelou V. Short-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: a prospective study. Epilepsy Res. 2014; 108:820-3.
[30]
Dinopoulos A, Stefanou MI, Attilakos A, Tsirouda M, Papaevangelou V. A case of startle epilepsy associated with IL1RAPL1 gene deletion. Pediatr Neurol. 2014; 51:271-4.
[31]
Vassiliki P, Ioanna K, Artemis V, Eleni K, Aglaia Z, Attilakos A, Maria T, Dimitris K. Determinants of vaccination coverage and adherence to the Greek national immunization program among infants aged 2-24 months at the beginning of the economic crisis (2009-2011). BMC Public Health. 2014; 14:1192.
[32]
Dinopoulos A, Attilakos A, Paschalidou M, Tsirouda M, Garoufi A, Siafakas N, Douros K. Response to "No clinically significant lymphocyte count change in pediatric patients treated with levetiracetam". Epilepsy Res. 2015; 114:149-50.
[33]
Garoufi A, Vartzelis G, Tsentidis C, Attilakos A, Koemtzidou E, Kossiva L, Katsarou E, Soldatou A. Weight gain in children on oxcarbazepine monotherapy. Epilepsy Res. 2016 May;122:110-3
[34]
Attilakos A, Dinopoulos A, Paschalidou M, Tsirouda M, Karalexi M, Prasouli A, Garoufi A. Long-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study. Epilepsy Res. 2018 Sep;145:160-162
[35]
Attilakos A, Garoufi A, Paschalidou M, Tsirouda M, Siafakas N, Dinopoulos A. Serum sodium, potassium, and magnesium in children with epilepsy treated with levetiracetam monotherapy: A prospective study. CNS Neurosci Ther. 2018.
0 Profile Views
35 Publications

Editorial Roles